Non-coding genetic variants in human disease

Human Molecular Genetics

Volumn 24, Issue R1, 2015, Pages R102-R110

  Zhang, Feng ^a   Lupski, James R ^b,c,d  

^a FUDAN UNIVERSITY   (China)

^b Department of Molecular and Human Genetics ^*  (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; AUTOSOMAL RECESSIVE INHERITANCE; BIOLOGICAL FUNCTIONS; BONE DYSPLASIA; CHROMATIN; CONGENITAL DISORDER; COPY NUMBER VARIATION; DYSCHONDROSTEOSIS; GENE DELETION; GENE FUNCTION; GENE INTERACTION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC TRAIT; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; HUMAN GENOME; HYPERTRIGLYCERIDEMIA; INHERITANCE; MOLECULAR BIOLOGY; MOLECULAR DIAGNOSIS; MOLECULAR GENETICS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE TRAIT LOCUS; REVIEW; RNA EDITING; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE NUCLEOTIDE VARIANT; SPASTIC PARAPLEGIA; STEM CELL; ANIMAL; DISEASES; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; REGULATORY SEQUENCE;

ANIMALS; DISEASE; DNA COPY NUMBER VARIATIONS; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; REGULATORY SEQUENCES, NUCLEIC ACID;

EID: 84943752520     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv259     Document Type: Review

References (88)

1. The Encode Project Consortium. (2012) An integrated encyclopedia of DNA elements in the human genome. Nature, 489, 57-74.
2. Graur, D., Zheng, Y., Price, N., Azevedo, R.B., Zufall, R.A. and Elhaik, E. (2013) On the immortality of television sets: "function" in the human genome according to the evolution-free gospel of ENCODE. Genome Biol. Evol., 5, 578-590.
3. Ahonen, T., Saltevo, J., Laakso, M., Kautiainen, H., Kumpusalo, E. and Vanhala, M. (2009) Gender differences relating to metabolic syndrome and proinflammation in Finnish subjects with elevated blood pressure. Mediators Inflamm., 2009, 959281.
4. Degner, J.F., Pai, A.A., Pique-Regi, R., Veyrieras, J.B., Gaffney, D. J., Pickrell, J.K., De Leon, S., Michelini, K., Lewellen, N., Crawford, G.E. et al. (2012) DNase I sensitivity QTLs are a major determinant of human expression variation. Nature, 482, 390-394.
5. Trynka, G., Sandor, C., Han, B., Xu, H., Stranger, B.E., Liu, X.S. and Raychaudhuri, S. (2013) Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat. Genet., 45, 124-130.
6. Edwards, S.L., Beesley, J., French, J.D. and Dunning, A.M. (2013) Beyond GWASs: illuminating the dark road from association to function. Am. J. Hum. Genet., 93, 779-797.
7. Arking, D.E., Pfeufer, A., Post, W., Kao, W.H., Newton-Cheh, C., Ikeda, M., West, K., Kashuk, C., Akyol, M., Perz, S. et al. (2006) A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat. Genet., 38, 644-651.
8. Kapoor, A., Sekar, R.B., Hansen, N.F., Fox-Talbot, K., Morley, M., Pihur, V., Chatterjee, S., Brandimarto, J., Moravec, C.S., Pulit, S.L. et al. (2014) An enhancer polymorphism at the cardiomyocyte intercalated disc protein NOS1AP locus is a major regulator of the QT interval. Am. J. Hum. Genet., 94, 854-869.
9. Spieler, D., Kaffe, M., Knauf, F., Bessa, J., Tena, J.J., Giesert, F., Schormair, B., Tilch, E., Lee, H., Horsch, M. et al. (2014) Restless legs syndrome-associated intronic common variant in Meis1 alters enhancer function in the developing telencephalon. Genome Res., 24, 592-603.
10. Bauer, D.E., Kamran, S.C., Lessard, S., Xu, J., Fujiwara, Y., Lin, C., Shao, Z., Canver, M.C., Smith, E.C., Pinello, L. et al. (2013) An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science, 342, 253-257.
11. Stadhouders, R., Aktuna, S., Thongjuea, S., Aghajanirefah, A., Pourfarzad, F., van Ijcken, W., Lenhard, B., Rooks, H., Best, S., Menzel, S. et al. (2014) HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers. J. Clin. Invest., 124, 1699-1710.
12. Weedon, M.N., Cebola, I., Patch, A.M., Flanagan, S.E., De Franco, E., Caswell, R., Rodriguez-Segui, S.A., Shaw-Smith, C., Cho, C.H., Lango Allen, H. et al. (2014) Recessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis. Nat. Genet., 46, 61-64.
13. Patwardhan, R.P., Hiatt, J.B., Witten, D.M., Kim, M.J., Smith, R. P., May, D., Lee, C., Andrie, J.M., Lee, S.I., Cooper, G.M. et al. (2012) Massively parallel functional dissection of mammalian enhancers in vivo. Nat. Biotechnol., 30, 265-270.
14. Melnikov, A., Murugan, A., Zhang, X., Tesileanu, T., Wang, L., Rogov, P., Feizi, S., Gnirke, A., Callan, C.G. Jr, Kinney, J.B. et al. (2012) Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assay. Nat. Biotechnol., 30, 271-277.
15. Duan, J., Shi, J., Fiorentino, A., Leites, C., Chen, X., Moy, W., Chen, J., Alexandrov, B.S., Usheva, A., He, D. et al. (2014) A rare functional noncoding variant at the GWAS-implicated MIR137/MIR2682 locus might confer risk to schizophrenia and bipolar disorder. Am. J. Hum. Genet., 95, 744-753.
16. Bhartiya, D., Jalali, S., Ghosh, S. and Scaria, V. (2014) Distinct patterns of genetic variations in potential functional elements in long noncoding RNAs. Hum. Mutat., 35, 192-201.
17. Stancakova, A., Javorsky, M., Kuulasmaa, T., Haffner, S.M., Kuusisto, J. and Laakso, M. (2009) Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes, 58, 1212-1221.
18. Kulzer, J.R., Stitzel, M.L., Morken, M.A., Huyghe, J.R., Fuchsberger, C., Kuusisto, J., Laakso, M., Boehnke, M., Collins, F.S. and Mohlke, K.L. (2014) A common functional regulatory variant at a type 2 diabetes locus upregulates ARAP1 expression in the pancreatic beta cell. Am. J. Hum. Genet., 94, 186-197.
19. Caussy, C., Charriere, S., Marcais, C., Di Filippo, M., Sassolas A., Delay, M., Euthine, V., Jalabert, A., Lefai, E., Rome, S. et al. (2014) An APOA5 3' UTR variant associated with plasma triglycerides triggers APOA5 downregulation by creating a functional miR-485-5p binding site. Am. J. Hum. Genet., 94, 129-134.
20. Ripke, S., O'Dushlaine, C., Chambert, K., Moran, J.L., Kahler, A. K., Akterin, S., Bergen, S.E., Collins, A.L., Crowley, J.J., Fromer, M. et al. (2013) Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet., 45, 1150-1159.
21. Roussos, P., Mitchell, A.C., Voloudakis, G., Fullard, J.F., Pothula, V.M., Tsang, J., Stahl, E.A., Georgakopoulos, A., Ruderfer, D. M., Charney, A. et al. (2014) A role for noncoding variation in schizophrenia. Cell Rep., 9, 1417-1429.
22. Heidari, N., Phanstiel, D.H., He, C., Grubert, F., Jahanbani, F., Kasowski, M., Zhang, M.Q. and Snyder, M.P. (2014) Genomewide map of regulatory interactions in the human genome. Genome Res., 24, 1905-1917.
23. Gheldof, N., Witwicki, R.M., Migliavacca, E., Leleu, M., Didelot, G., Harewood, L., Rougemont, J. and Reymond, A. (2013) Structural variation-associated expression changes are paralleled by chromatin architecture modifications. PLoS One, 8, e79973.
24. van deWerken, H.J., Landan, G., Holwerda, S.J., Hoichman, M., Klous, P., Chachik, R., Splinter, E., Valdes-Quezada, C., Oz, Y., Bouwman, B.A. et al. (2012) Robust 4C-seq data analysis to screen for regulatory DNA interactions. Nat. Methods, 9, 969-972.
25. Hughes, J.R., Roberts, N., McGowan, S., Hay, D., Giannoulatou, E., Lynch, M., De Gobbi, M., Taylor, S., Gibbons, R. and Higgs, D. R. (2014) Analysis of hundreds of cis-regulatory landscapes at high resolution in a single, high-throughput experiment. Nat. Genet., 46, 205-212.
26. Rao, S.S., Huntley, M.H., Durand, N.C., Stamenova, E.K., Bochkov, I.D., Robinson, J.T., Sanborn, A.L., Machol, I., Omer, A.D., Lander, E.S. et al. (2014) A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell, 159, 1665-1680.
27. Pai, A.A., Pritchard, J.K. and Gilad, Y. (2015) The genetic and mechanistic basis for variation in gene regulation. PLoS Genet., 11, e1004857.
28. Zhang, X., Joehanes, R., Chen, B.H., Huan, T., Ying, S., Munson, P.J., Johnson, A.D., Levy, D. and O'Donnell, C.J. (2015) Identification of common genetic variants controlling transcript isoform variation in human whole blood. Nat. Genet., 47, 345-352.
29. Rhind, N. and Gilbert, D.M. (2013)DNAreplication timing. Cold Spring Harb. Perspect. Biol., 5, a010132.
30. Koren, A., Handsaker, R.E., Kamitaki, N., Karlic, R., Ghosh, S., Polak, P., Eggan, K. and McCarroll, S.A. (2014) Genetic variation in human DNA replication timing. Cell, 159, 1015-1026.
31. Ritchie, G.R., Dunham, I., Zeggini, E. and Flicek, P. (2014) Functional annotation of noncoding sequence variants. Nat. Methods, 11, 294-296.
32. Stenson, P.D., Mort, M., Ball, E.V., Howells, K., Phillips, A.D., Thomas, N.S. and Cooper, D.N. (2009) The Human Gene Mutation Database: 2008 update. Genome Med., 1, 13.
33. The 1000 Genomes Project ConsortiumAbecasis, G.R., Auton, A., Brooks, L.D., DePristo, M.A., Durbin, R.M., Handsaker, R.E., Kang, H.M., Marth, G.T. and McVean, G.A. (2012) An integrated map of genetic variation from 1,092 human genomes. Nature, 491, 56-65.
34. Kircher, M., Witten, D.M., Jain, P., O'Roak, B.J., Cooper, G.M. and Shendure, J. (2014) A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet., 46, 310-315.
35. Ricard, G., Molina, J., Chrast, J., Gu, W., Gheldof, N., Pradervand, S., Schutz, F., Young, J.I., Lupski, J.R., Reymond, A. et al. (2010) Phenotypic consequences of copy number variation: insights from Smith-Magenis and Potocki-Lupski syndrome mouse models. PLoS Biol., 8, e1000543.
36. Walz, K., Paylor, R., Yan, J., Bi, W. and Lupski, J.R. (2006) Rai1 duplication causes physical and behavioral phenotypes in a mouse model of dup(17)(p11.2p11.2). J. Clin. Invest., 116, 3035-3041.
37. Lacaria, M., Spencer, C., Gu, W., Paylor, R. and Lupski, J.R. (2012) Enriched rearing improves behavioral responses of an animal model for CNV-based autistic-like traits. Hum. Mol. Genet., 21, 3083-3096.
38. Lacaria, M., Saha, P., Potocki, L., Bi, W., Yan, J., Girirajan, S., Burns, B., Elsea, S., Walz, K., Chan, L. et al. (2012) A duplication CNV that conveys traits reciprocal to metabolic syndrome and protects against diet-induced obesity in mice and men. PLoS Genet., 8, e1002713.
39. Shalem, O., Sanjana, N.E. and Zhang, F. (2015) High-throughput functional genomics using CRISPR-Cas9. Nat. Rev. Genet., 16, 299-311.
40. Kraft, K., Geuer, S., Will, A.J., Chan, W.L., Paliou, C., Borschiwer, M., Harabula, I., Wittler, L., Franke, M., Ibrahim, D.M. et al. (2015) Deletions, inversions, duplications: engineering of structural variants using CRISPR/Cas in mice. Cell Rep., 10, 833-839.
41. Donnelly, C.J., Zhang, P.W., Pham, J.T., Haeusler, A.R., Mistry, N.A., Vidensky, S., Daley, E.L., Poth, E.M., Hoover, B., Fines, D. M. et al. (2013) RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron, 80, 415-428.
42. Sareen, D., O'Rourke, J.G., Meera, P., Muhammad, A.K., Grant, S., Simpkinson, M., Bell, S., Carmona, S., Ornelas, L., Sahabian, A. et al. (2013) Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci. Transl. Med., 5, 208ra149.
43. Lupski, J.R. (1998) Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. Trends Genet., 14, 417-422.
44. Lee, C. and Morton, C.C. (2008) Structural genomic variation and personalized medicine. N. Engl. J. Med., 358, 740-741.
45. Lupski, J.R. (2009) Genomic disorders ten years on. Genome Med., 1, 42.
46. Lupski, J.R. (2015) Structural variation mutagenesis of the human genome: impact on disease and evolution. Environ. Mol. Mutagen., 56, doi: 10.1002/em.21943.
47. Lupski, J.R. and Stankiewicz, P. (2005) Genomic disorders: molecular mechanisms for rearrangements and conveyed phenotypes. PLoS Genet., 1, e49.
48. de Kok, Y.J., Vossenaar, E.R., Cremers, C.W., Dahl, N., Laporte, J., Hu, L.J., Lacombe, D., Fischel-Ghodsian, N., Friedman, R.A., Parnes, L.S. et al. (1996) Identification of a hot spot for microdeletions in patients with X-linked deafness type 3 (DFN3) 900 kb proximal to the DFN3 gene POU3F4. Hum. Mol. Genet., 5, 1229-1235.
49. McCarroll, S.A., Huett, A., Kuballa, P., Chilewski, S.D., Landry, A., Goyette, P., Zody, M.C., Hall, J.L., Brant, S.R., Cho, J.H. et al. (2008) Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat. Genet., 40, 1107-1112.
50. Smyk, M., Berg, J.S., Pursley, A., Curtis, F.K., Fernandez, B.A., Bien-Willner, G.A., Lupski, J.R., Cheung, S.W. and Stankiewicz, P. (2007) Male-to-female sex reversal associated with an approximately 250 kb deletion upstream of NR0B1 (DAX1). Hum. Genet., 122, 63-70.
51. Zhang, F., Seeman, P., Liu, P., Weterman, M.A., Gonzaga-Jauregui, C., Towne, C.F., Batish, S.D., De Vriendt, E., De Jonghe, P., Rautenstrauss, B. et al. (2010) Mechanisms for nonrecurrent genomic rearrangements associated with CMT1A or HNPP: rare CNVs as a cause for missing heritability. Am. J. Hum. Genet., 86, 892-903.
52. Weterman, M.A., van Ruissen, F., deWissel, M., Bordewijk, L., Samijn, J.P., van der Pol, W.L., Meggouh, F. and Baas, F. (2010) Copy number variation upstream of PMP22 in Charcot-Marie-Tooth disease. Eur. J. Hum. Genet., 18, 421-428.
53. Benito-Sanz, S., Royo, J.L., Barroso, E., Paumard-Hernandez, B., Barreda-Bonis, A.C., Liu, P., Gracia, R., Lupski, J.R., Campos-Barros, A., Gomez-Skarmeta, J.L. et al. (2012) Identification of the first recurrent PAR1 deletion in Leri-Weill dyschondrosteosis and idiopathic short stature reveals the presence of a novel SHOX enhancer. J. Med. Genet., 49, 442-450.
54. Lee, J.A., Madrid, R.E., Sperle, K., Ritterson, C.M., Hobson, G.M., Garbern, J., Lupski, J.R. and Inoue, K. (2006) Spastic paraplegia type 2 associated with axonal neuropathy and apparent PLP1 position effect. Ann. Neurol., 59, 398-403.
55. Pop, R., Conz, C., Lindenberg, K.S., Blesson, S., Schmalenberger, B., Briault, S., Pfeifer, D. and Scherer, G. (2004) Screening of the 1 Mb SOX9 5' control region by array CGH identifies a large deletion in a case of campomelic dysplasia with XY sex reversal. J. Med. Genet., 41, e47.
56. Cox, J.J., Willatt, L., Homfray, T. andWoods, C.G. (2011) A SOX9 duplication and familial 46, XX developmental testicular disorder. N. Engl. J. Med., 364, 91-93.
57. Benko, S., Fantes, J.A., Amiel, J., Kleinjan, D.J., Thomas, S., Ramsay, J., Jamshidi, N., Essafi, A., Heaney, S., Gordon, C.T. et al. (2009) Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence. Nat. Genet., 41, 359-364.
58. Kurth, I., Klopocki, E., Stricker, S., van Oosterwijk, J., Vanek, S., Altmann, J., Santos, H.G., van Harssel, J.J., de Ravel, T., Wilkie, A.O. et al. (2009) Duplications of noncoding elements 5' of SOX9 are associated with brachydactyly-anonychia. Nat. Genet., 41, 862-863.
59. Lupianez, D.G., Kraft, K., Heinrich, V., Krawitz, P., Brancati, F., Klopocki, E., Horn, D., Kayserili, H., Opitz, J.M., Laxova, R. et al. (2015) Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions. Cell, 161, 1012-1025.
60. Bien-Willner, G.A., Stankiewicz, P. and Lupski, J.R. (2007) SOX9cre1, a cis-acting regulatory element located 1.1 Mb upstream of SOX9, mediates its enhancement through the SHH pathway. Hum. Mol. Genet., 16, 1143-1156.
61. Blumenthal, I., Ragavendran, A., Erdin, S., Klei, L., Sugathan, A., Guide, J.R., Manavalan, P., Zhou, J.Q., Wheeler, V.C., Levin, J.Z. et al. (2014) Transcriptional consequences of 16p11.2 deletion and duplication in mouse cortex and multiplex autism families. Am. J. Hum. Genet., 94, 870-883.
62. Szafranski, P., Dharmadhikari, A.V., Brosens, E., Gurha, P., Kolodziejska, K.E., Zhishuo, O., Dittwald, P., Majewski, T., Mohan, K.N., Chen, B. et al. (2013) Small noncoding differentially methylated copy-number variants, including lncRNA genes, cause a lethal lung developmental disorder. Genome Res., 23, 23-33.
63. Zhang, F., Gu, W., Hurles, M.E. and Lupski, J.R. (2009) Copy number variation in human health, disease, and evolution. Annu. Rev. Genomics Hum. Genet., 10, 451-481.
64. Reddy, U.M., Page, G.P., Saade, G.R., Silver, R.M., Thorsten, V. R., Parker, C.B., Pinar, H., Willinger, M., Stoll, B.J., Heim-Hall, J. et al. (2012) Karyotype versus microarray testing for genetic abnormalities after stillbirth. N. Engl. J. Med., 367, 2185-2193.
65. Wapner, R.J., Martin, C.L., Levy, B., Ballif, B.C., Eng, C.M., Zachary, J.M., Savage, M., Platt, L.D., Saltzman, D., Grobman, W.A. et al. (2012) Chromosomal microarray versus karyotyping for prenatal diagnosis. N. Engl. J. Med., 367, 2175-2184.
66. Klopocki, E., Schulze, H., Strauss, G., Ott, C.E., Hall, J., Trotier, F., Fleischhauer, S., Greenhalgh, L., Newbury-Ecob, R.A., Neumann, L.M. et al. (2007) Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome. Am. J. Hum. Genet., 80, 232-240.
67. Albers, C.A., Paul, D.S., Schulze, H., Freson, K., Stephens, J.C., Smethurst, P.A., Jolley, J.D., Cvejic, A., Kostadima, M., Bertone, P. et al. (2012) Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome. Nat. Genet., 44, 435-439.
68. Wieczorek, D., Newman, W.G., Wieland, T., Berulava, T., Kaffe, M., Falkenstein, D., Beetz, C., Graf, E., Schwarzmayr, T., Douzgou, S. et al. (2014) Compound heterozygosity of low-frequency promoter deletions and rare loss-of-function mutations in TXNL4A causes Burn-McKeown syndrome. Am. J. Hum. Genet., 95, 698-707.
69. Wu, N., Ming, X., Xiao, J., Wu, Z., Chen, X., Shinawi, M., Shen, Y., Yu, G., Liu, J., Xie, H. et al. (2015) TBX6 null variants and a common hypomorphic allele in congenital scoliosis. N. Engl. J. Med., 372, 341-350.
70. Weiss, L.A., Shen, Y., Korn, J.M., Arking, D.E., Miller, D.T., Fossdal, R., Saemundsen, E., Stefansson, H., Ferreira, M.A., Green, T. et al. (2008) Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med., 358, 667-675.
71. Kumar, R.A., KaraMohamed, S., Sudi, J., Conrad, D.F., Brune, C., Badner, J.A., Gilliam, T.C., Nowak, N.J., Cook, E.H. Jr, Dobyns, W.B. et al. (2008) Recurrent 16p11.2 microdeletions in autism. Hum. Mol. Genet., 17, 628-638.
72. Walters, R.G., Jacquemont, S., Valsesia, A., de Smith, A.J., Martinet, D., Andersson, J., Falchi, M., Chen, F., Andrieux, J., Lobbens, S. et al. (2010) A new highly penetrant form of obesity due to deletions on chromosome16p11.2. Nature, 463, 671-675.
73. Jacquemont, S., Reymond, A., Zufferey, F., Harewood, L., Walters, R.G., Kutalik, Z., Martinet, D., Shen, Y., Valsesia, A., Beckmann, N.D. et al. (2011) Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. Nature, 478, 97-102.
74. Sandbacka, M., Laivuori, H., Freitas, E., Halttunen, M., Jokimaa, V., Morin-Papunen, L., Rosenberg, C. and Aittomaki, K. (2013) TBX6, LHX1 and copy number variations in the complex genetics of Mullerian aplasia. Orphanet. J. Rare Dis., 8, 125.
75. Shimojima, K., Inoue, T., Fujii, Y., Ohno, K. and Yamamoto, T. (2009) A familial 593-kb microdeletion of 16p11.2 associated with mental retardation and hemivertebrae. Eur. J. Med. Genet., 52, 433-435.
76. Shen, Y., Chen, X., Wang, L., Guo, J., Shen, J., An, Y., Zhu, H., Zhu, Y., Xin, R., Bao, Y. et al. (2011) Intra-family phenotypic heterogeneity of 16p11.2 deletion carriers in a three-generation Chinese family. Am. J. Med. Genet. B Neuropsychiatr. Genet., 156, 225-232.
77. Al-Kateb, H., Khanna, G., Filges, I., Hauser, N., Grange, D.K., Shen, J., Smyser, C.D., Kulkarni, S. and Shinawi, M. (2014) Scoliosis and vertebral anomalies: additional abnormal phenotypes associated with chromosome 16p11.2 rearrangement. Am. J. Med. Genet. A, 164A, 1118-1126.
78. Lupski, J.R., Belmont, J.W., Boerwinkle, E. and Gibbs, R.A. (2011) Clan genomics and the complex architecture of human disease. Cell, 147, 32-43.
79. Kurotaki, N., Shen, J.J., Touyama, M., Kondoh, T., Visser, R., Ozaki, T., Nishimoto, J., Shiihara, T., Uetake, K., Makita, Y. et al. (2005) Phenotypic consequences of genetic variation at hemizygous alleles: Sotos syndrome is a contiguous gene syndrome incorporating coagulation factor twelve (FXII) deficiency. Genet. Med., 7, 479-483.
80. Shiow, L.R., Paris, K., Akana, M.C., Cyster, J.G., Sorensen, R.U. and Puck, J.M. (2009) Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion. Clin. Immunol., 131, 24-30.
81. Yang, Y., Muzny, D.M., Reid, J.G., Bainbridge, M.N., Willis, A., Ward, P.A., Braxton, A., Beuten, J., Xia, F., Niu, Z. et al. (2013) Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N. Engl. J. Med., 369, 1502-1511.
82. Yang, Y., Muzny, D.M., Xia, F., Niu, Z., Person, R., Ding, Y., Ward, P., Braxton, A., Wang, M., Buhay, C. et al. (2014) Molecular findings among patients referred for clinical whole-exome sequencing. JAMA, 312, 1870-1879.
83. Chong, J.X., Buckingham, K.J., Jhangiani, S.N., Boehm, C., Sobreira, N., Smith, J.D., Harrell, T.M., McMillin, M.J., Wiszniewski, W., Gambin, T. et al. (2015) The genetic basis of Mendelian phenotypes: discoveries, challenges, and ppportunities. Am. J. Hum. Genet., 97, doi: 10.1016/j.ajhg.2015.06.009.
84. Lupski, J.R., Reid, J.G., Gonzaga-Jauregui, C., Rio Deiros, D., Chen, D.C., Nazareth, L., Bainbridge, M., Dinh, H., Jing, C., Wheeler, D.A. et al. (2010) Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N. Engl. J. Med., 362, 1181-1191.
85. Taylor, J.C., Martin, H.C., Lise, S., Broxholme, J., Cazier, J.B., Rimmer, A., Kanapin, A., Lunter, G., Fiddy, S., Allan, C. et al. (2015) Factors influencing success of clinical genome sequencing across a broad spectrum of disorders. Nat. Genet., 47, 717-726.
86. Bauer, D.E., Kamran, S.C., Lessard, S., Xu, J., Fujiwara, Y., Lin, C., Shao, Z., Canver, M.C., Smith, E.C., Pinello, L. et al. (2013) An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science, 342, 253-257.
87. Stadhouders, R., Aktuna, S., Thongjuea, S., Aghajanirefah, A., Pourfarzad, F., van Ijcken, W., Lenhard, B., Rooks, H., Best, S., Menzel, S. et al. (2014) HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers. J. Clin. Invest., 124, 1699-1710.
88. Weedon, M.N., Cebola, I., Patch, A.M., Flanagan, S.E., De Franco, E., Caswell, R., Rodriguez-Segui, S.A., Shaw-Smith, C., Cho, C.H., Lango Allen, H. et al. (2014) Recessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis. Nat. Genet., 46, 61-64.